Jude Onyia

Chief Scientific Officer, Neurocrine Biosciences

Bought, 12 months

$0.0M

Sold, 12 months

$3.5M

Companies

Latest trade

Jun 1, 2026

Companies

Neurocrine BiosciencesChief Scientific Officer −$3.5M

Trades

NBIX Sold 11,000 shares at $160.25 · planned $1.8M Jun 1

NBIX Sold 11,000 shares at $155.53 · planned $1.7M May 27

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.